# Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy

> **NCT06516419** · NA · RECRUITING · sponsor: **Dr.dr.Irma Bernadette, SpKK (K)** · enrollment: 90 (estimated)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Concentrated secretome Injection 2mL
- **DRUG:** Tranexamic acid injection
- **DRUG:** Triple Combination Cream

## Key facts

- **NCT ID:** NCT06516419
- **Lead sponsor:** Dr.dr.Irma Bernadette, SpKK (K)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-13
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06516419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06516419, "Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06516419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*